Last update: May 17th 2013
April 23th 2013

Choose Transparency: A message to the Members...

The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society representatives we would like to draw your attention not only to the dangers it encompasses but also to the opportunities it brings along.

April 09th 2013

Clinical Trials Regulation Protect public...

The International Society of Drug Bulletins issued a statement today to the members of European Parlament to request:

  • support amendments that require the public disclosure of a complete clinical studyreport (CSR) as outlined by ENVI rapporteur MEP...
February 05th 2013

New Proposal for a Regulation on Clinical Trials

The protection of human subjects must be upheld & citizens’ right to information must be strengthened

September 15th 2012

European Medicines Agency and...

On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be charged by the European Medicines Agency for pharmacovigilance”.

for members only

Campaigns - Regulatory issues

August 16th 2012

Comments on Quality Review of Documents (QRD): revision of the product information - Draft

Submission of comments on 'Quality Review of Documents (QRD) human product information annotated template: revision of the product information - Draft' (EMA/468498/2012)

read (268 KB)

Latest Campaigns

ISDB - International Society of Drug bullettins

Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it

© 2013